CA1052697A - Composition for treating mastitis in animals - Google Patents
Composition for treating mastitis in animalsInfo
- Publication number
- CA1052697A CA1052697A CA221,421A CA221421A CA1052697A CA 1052697 A CA1052697 A CA 1052697A CA 221421 A CA221421 A CA 221421A CA 1052697 A CA1052697 A CA 1052697A
- Authority
- CA
- Canada
- Prior art keywords
- fatty acid
- composition
- oil
- group
- mastitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 208000004396 mastitis Diseases 0.000 title claims abstract description 28
- 241001465754 Metazoa Species 0.000 title claims abstract description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 24
- 239000000194 fatty acid Substances 0.000 claims abstract description 24
- 229930195729 fatty acid Natural products 0.000 claims abstract description 24
- -1 fatty acid ester Chemical class 0.000 claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 16
- 238000001802 infusion Methods 0.000 claims abstract description 14
- 235000013336 milk Nutrition 0.000 claims abstract description 10
- 239000008267 milk Substances 0.000 claims abstract description 10
- 210000004080 milk Anatomy 0.000 claims abstract description 10
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 20
- 239000003921 oil Substances 0.000 claims description 19
- 235000019198 oils Nutrition 0.000 claims description 19
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 14
- 239000008158 vegetable oil Substances 0.000 claims description 14
- 235000019483 Peanut oil Nutrition 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 239000000312 peanut oil Substances 0.000 claims description 12
- 239000003981 vehicle Substances 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims description 8
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims description 8
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 150000002763 monocarboxylic acids Chemical class 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 229940114930 potassium stearate Drugs 0.000 claims description 5
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical group [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000002480 mineral oil Substances 0.000 description 6
- 235000010446 mineral oil Nutrition 0.000 description 6
- 229940114926 stearate Drugs 0.000 description 5
- 235000017060 Arachis glabrata Nutrition 0.000 description 4
- 244000105624 Arachis hypogaea Species 0.000 description 4
- 235000010777 Arachis hypogaea Nutrition 0.000 description 4
- 235000018262 Arachis monticola Nutrition 0.000 description 4
- 201000006747 infectious mononucleosis Diseases 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 235000020232 peanut Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 3
- 210000005075 mammary gland Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 208000031462 Bovine Mastitis Diseases 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 2
- 229960002950 novobiocin Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- WWPRGAYLRGSOSU-RNROJPEYSA-M Novobiocin sodium Chemical compound [Na+].O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C([O-])=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C WWPRGAYLRGSOSU-RNROJPEYSA-M 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 229960001595 lincomycin hydrochloride Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45603074A | 1974-03-29 | 1974-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1052697A true CA1052697A (en) | 1979-04-17 |
Family
ID=23811160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA221,421A Expired CA1052697A (en) | 1974-03-29 | 1975-03-06 | Composition for treating mastitis in animals |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE827361A (OSRAM) |
| CA (1) | CA1052697A (OSRAM) |
| DE (1) | DE2512391C2 (OSRAM) |
| DK (1) | DK143438C (OSRAM) |
| FR (1) | FR2265408B1 (OSRAM) |
| GB (1) | GB1456349A (OSRAM) |
| NL (1) | NL7502808A (OSRAM) |
| ZA (1) | ZA751451B (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1547164A (en) * | 1975-08-14 | 1979-06-06 | Beecham Group Ltd | Veterinary compositions |
| IT1190445B (it) * | 1985-11-08 | 1988-02-16 | Fatro Spa | Composizioni veterinarie a base di agenti antimicrobici e loro impiego |
| SE457693B (sv) * | 1986-07-01 | 1989-01-23 | Drilletten Ab | Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas |
| DK16290D0 (da) * | 1990-01-19 | 1990-01-19 | Spindel & Spinnfluegelfab Veb | Pattebehandlingsmiddel navnlig til bekaempelse af mastitis |
| GB2273443B (en) * | 1992-12-08 | 1997-01-08 | Bimeda Res Dev Ltd | Veterinary composition for the treatment of mastitis |
| CA2264286A1 (en) * | 1996-09-06 | 1998-03-12 | Minnesota Mining And Manufacturing Company | Antimicrobial compositions |
| CA2274796C (en) | 1996-12-18 | 2006-12-05 | Bimeda Research & Development Limited | Antiinfective free intramammary veterinary composition |
| FR2833500A1 (fr) * | 2001-12-17 | 2003-06-20 | Veyron Et Froment Lab | Gel huileux anhydre stabilise |
| NZ519112A (en) * | 2002-05-22 | 2004-12-24 | Interag | Drug delivery device for administration of active agent to mammary gland cavity |
| US7842791B2 (en) | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| US20040197422A1 (en) * | 2002-12-20 | 2004-10-07 | Pfizer Inc | Veterinary compositions for treating mastitis |
| GB0229642D0 (en) * | 2002-12-20 | 2003-01-22 | Pfizer Ltd | Veterinary compositions for treating mastitis |
| BRPI0507279A (pt) | 2004-02-02 | 2007-06-26 | Bimeda Res & Dev Ltd | método e dispositivo para o tratamento do canal da teta de um animal |
| NZ548748A (en) | 2004-02-02 | 2010-09-30 | Bimeda Res & Dev Ltd | Method and device for treating a teat canal of an animal |
| EP2079477B1 (en) | 2006-10-10 | 2017-07-26 | Wisconsin Alumni Research Foundation | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| AU2010234514B2 (en) * | 2009-04-08 | 2014-03-27 | Wisconsin Alumni Research Foundation | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
-
1975
- 1975-03-06 CA CA221,421A patent/CA1052697A/en not_active Expired
- 1975-03-10 ZA ZA00751451A patent/ZA751451B/xx unknown
- 1975-03-10 NL NL7502808A patent/NL7502808A/xx not_active Application Discontinuation
- 1975-03-14 DK DK106175A patent/DK143438C/da not_active IP Right Cessation
- 1975-03-21 DE DE2512391A patent/DE2512391C2/de not_active Expired
- 1975-03-28 FR FR7509948A patent/FR2265408B1/fr not_active Expired
- 1975-03-28 BE BE154927A patent/BE827361A/xx not_active IP Right Cessation
- 1975-04-01 GB GB1331075A patent/GB1456349A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7502808A (nl) | 1975-10-01 |
| DE2512391A1 (de) | 1975-10-02 |
| DE2512391C2 (de) | 1986-10-09 |
| FR2265408B1 (OSRAM) | 1978-08-04 |
| DK143438C (da) | 1981-12-21 |
| FR2265408A1 (OSRAM) | 1975-10-24 |
| GB1456349A (en) | 1976-11-24 |
| AU7909675A (en) | 1976-09-16 |
| ZA751451B (en) | 1976-02-25 |
| DK106175A (OSRAM) | 1975-09-30 |
| DK143438B (da) | 1981-08-24 |
| BE827361A (fr) | 1975-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1052697A (en) | Composition for treating mastitis in animals | |
| EP0022289B1 (en) | Antimicrobial polymer compositions and use thereof in medical devices | |
| US4479795A (en) | Antimicrobial polymer compositions | |
| JP2632842B2 (ja) | 抗菌保存組成物 | |
| Iba et al. | Studies on the use of a formic acid‐propionic acid mixture (Bio‐add™) to control experimental Salmonella infection in broiler chickens | |
| CA2366793C (en) | Propofol formulation with enhanced microbial characteristics | |
| DE69715259T3 (de) | Intramammäre tierarzneimittel ohne antiinfektiöse wirkstoffe | |
| US4034099A (en) | Compositions and method for treating mastitis in milk animals | |
| KR20160035571A (ko) | 가수분해 피브로인을 포함하는 연고 및 그 제조방법 | |
| MXPA05005319A (es) | Composiciones farmaceuticas que tienen un vehiculo modificado. | |
| CN107432834A (zh) | 一种具有抑菌效果的无防腐成分组合物及其制备方法和应用 | |
| CA2264286A1 (en) | Antimicrobial compositions | |
| TW201511779A (zh) | 包含奧澤沙星之醫藥局部組成物及其用途 | |
| KR20110101138A (ko) | 에멀젼계 치료학적 국소 제형용 보존 시스템 | |
| DD255667A5 (de) | Koeder fuer tiere | |
| CN112654369A (zh) | 生物相容性材料 | |
| CN104257684B (zh) | 奶牛乳头药浴涂膜剂及其制备方法 | |
| EP0180743A1 (de) | Lebende Mikroorganismen enthaltendes flüssiges Präparat, Verfahren zu dessen Herstellung, lebende Mikroorganismen enthaltendes pelletiertes Produkt und Verfahren zu dessen Herstellung | |
| CN110248702A (zh) | 对于油性皮肤的美容处理有用的组合物 | |
| KR20220043794A (ko) | 소독용 겔 조성물 및 이의 제조 방법 | |
| AU2016302401B2 (en) | Emollient composition | |
| DE833673C (de) | Verfahren zur Herstellung einer Schweinecholera-Lymphe | |
| JP4398187B2 (ja) | 保湿性手袋およびその製造法 | |
| US2793976A (en) | Method for controlling hemorrhage in dehorned cattle | |
| WO2002022171A2 (en) | Pharmaceutical composition having specific water activity |